Your email has been successfully added to our mailing list.

×
0.0318852543597152 0.0318852543597152 0.0318852543597152 0.0318852543597152 0.0318852543597152 0.0318852543597152 0.0318852543597152 0.0215664018161182
Stock impact report

Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases

PRANA BIOTECH (PRAN) 
US:NASDAQ Investor Relations: pranabio.com/investors
Company Research Source: Business Wire
Highlights: Prana receives ethics committee approval for a clinical trial evaluating first in human dosing of PBT434 Recruitment has commenced for the first cohort of healthy volunteers Study conducted by leading Australian early phase clinical trial facility Nucleus Network, in Melbourne, Australia PBT434 has been shown to prevent a-synuclein accumulation and neuron loss in experimental animal models of Parkinsonian diseases MELBOURNE, Australia & SAN FRANCISCO--(BUSINESS WIRE)-- Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce it has received ethics committee approval and has commenced recruitment for its Phase I Clinical trial evaluating the safety, tolerability and pharmacokinetics of the Company’s lead drug candidate, PBT434, in healthy volunteers. PBT434 is the first of a new generation of small molec Show less Read more
Impact Snapshot
Event Time:
PRAN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PRAN alerts
Opt-in for
PRAN alerts

from News Quantified
Opt-in for
PRAN alerts

from News Quantified